Increlex Injection
Product Images NDC 71863-216

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Increlex (NDC 71863-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eton Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Increlex 01)

A line graph depicting the mean total IGF-1 (ng/mL) levels over time (hours) for two different doses, 0.12 mg/kg and 0.06 mg/kg. The graph shows IGF-1 levels rising sharply then gradually declining over a 36-hour period, with higher levels observed for the 0.12 mg/kg dose.*

FDA Label Image

Image (Increlex 02)

An instructional illustration showing a vial of medication labeled with a rubber top and a protective cap being removed by hand. The diagram highlights the vial components and demonstrates the removal of the protective cap from the rubber top.*

FDA Label Image

Image (Increlex 03)

An instructional line drawing showing two hands, one stabilizing a vial and the other removing or placing a cap or stopper on the vial's top. The vial is held upright, with focus on the hand action relevant to handling or preparing the injection vial.*

FDA Label Image

Image (Increlex 04)

An instructional illustration showing a hand using a syringe to withdraw medication from a vial, indicated by an arrow pointing downward toward the vial's rubber stopper.*

FDA Label Image

Image (Increlex 05)

A black and white line drawing showing hands preparing an injection. One hand is holding a vial upside down, while the other hand holds a syringe drawing liquid from the vial. The image illustrates the step of medication preparation for subcutaneous injection.*

FDA Label Image

Image (Increlex 06)

An instructional illustration showing hands preparing a syringe by drawing liquid from a vial. The image depicts one hand holding the vial upside down and the other hand pulling the syringe plunger to fill it with medication.*

FDA Label Image

Image (Increlex 07)

An instructional illustration showing hands using a syringe to draw fluid from a vial. One hand holds the vial while the other pulls back the syringe plunger, with an arrow indicating the drawing motion.*

FDA Label Image

Image (Increlex 08)

An instructional line drawing showing a hand holding a syringe with the needle inserted into a vial. The illustration likely depicts the preparation or withdrawal of medication from the vial into the syringe for injection.*

FDA Label Image

Image (Increlex 09)

An instructional illustration showing a hand holding a syringe, prepared for injection. The syringe is positioned vertically with the plunger at the top, and the hand is grasping the syringe barrel firmly, suggesting it is ready for subcutaneous administration.*

FDA Label Image

Image (Increlex 10)

An illustration showing two views of a person's upper arm and shoulder from the back and side. Both views highlight the injection site on the upper arm, indicated by a shaded oval area, likely demonstrating the subcutaneous injection site for Increlex (Mecasermin) injection.*

FDA Label Image

Image (Increlex 11)

An instructional illustration depicting the recommended subcutaneous injection sites for Increlex (Mecasermin). The image highlights areas on the outer thighs and upper arms with shaded circles to indicate appropriate injection locations.*

FDA Label Image

Image (Increlex 12)

An anatomical illustration showing the front and back views of the human torso, highlighting the shoulder area, likely indicating target sites for subcutaneous injection administration.*

FDA Label Image

Image (Increlex 13)

An illustration depicting the recommended subcutaneous injection sites on the body. It shows the front view of a torso with two shaded circular areas located on the abdomen, slightly to the left and right of the navel, indicating where the injection should be administered.*

FDA Label Image

Image (Increlex 14)

An instructional line drawing depicting a hand holding a syringe with the needle angled downward towards the skin, suggesting subcutaneous injection technique. A downward arrow indicates the motion of administering the injection into the skin fold held by the other hand.*

FDA Label Image

Image (Increlex 15)

A black and white line drawing showing a human hand holding a small, rounded packet or wipe, pinched between the thumb and fingers. The illustration appears instructional, likely demonstrating cleaning or prep before injection.*

FDA Label Image

Principal Display Panel (4 mL Vial Carton)

Box packaging label for Increlex (mecasermin) injection 40 mg/4 mL (10 mg/mL) by Eton Pharmaceuticals, Inc. The label is for a 4 mL multiple-dose vial intended for subcutaneous use. It includes manufacturing details, storage instructions to refrigerate between 2-8°C and protect from light, a barcode, and a list of inactive ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.